search icon
Join IDSAJOIN IDSA >> Go to MyIDSAGO TO MYIDSA >>
  • Print
  • ShareThis
  • Text Size

IDSA News Releases

05/23/2017

IDSA Statement on the President’s Fiscal Year 2018 Budget Proposal

The Infectious Diseases Society of America urges Congress to reject the short-sighted and destructive approach to research and public health evidenced in the Trump administration’s proposed budget for 2018 Trump administration’s FY2018 budget.
05/22/2017

IDSA Welcomes World Health Assembly Update on Antimicrobial Resistance

The Infectious Diseases Society of America welcomes an update at the World Health Assembly demonstrating progress on the implementation of the global action plan on antimicrobial resistance adopted by the United Nations General Assembly in September 2016.
05/15/2017

Medical, science organizations call on Price to support National Institutes of Health

Inadvance of a May 17 U.S. House of Representatives hearing on funding for the National Institutes of Health, leaders of 27 major medical and scientific societies and research advocacy organizations asked Health and Human Services Director Tom Price to protect the National Institutes of Health and its Fogarty International Center in a letter outlining the Center’s critical contributions to health security and responses at home and abroad
05/05/2017

IDSA Statement on FY2017 Omnibus Funding Legislation

The Infectious Diseases Society of America (IDSA) is grateful to Congress for passing H.R. 244, the Consolidated Appropriations Act, with its support for valuable infectious disease programs that will help protect public health in the United States and around the world.
04/10/2017

IDSA Education and Research Foundation Names Simintha Esson as New Chief Development Officer

Arlington, VA—The Infectious Diseases Society of America (IDSA) has named Simintha Esson to be Chief Development Officer (CDO) of the IDSA Education and Research Foundation, which serves as the charitable arm of the Society. Ms. Esson joins the Foundation at a time when the spread of diseases such as Zika and the resurgence of diseases long since considered under control like malaria and cholera are drawing considerable national attention.  
03/31/2017

Tax Credit Bill Introduced

The undersigned organizations representing healthcare providers, hospitals, pharmacists, scientists and microbiologists, industry, public health experts, patients and advocates write to express our support for the Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act of 2017, H.R. 1840.
03/28/2017

IDSA and HIVMA Statement on Trump Proposed FY2017 Cuts

The Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA) are alarmed by the Trump administration’s proposed cuts to FY2017 funding for the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC) public health preparedness and response grants, global and domestic HIV and TB efforts at the CDC, and global health programs at the United States Agency for International Development (USAID) and the State Department.
03/16/2017

IDSA Statement on the Trump Budget Blueprint

The Infectious Diseases Society of America (IDSA) is deeply troubled that the budget blueprint released today by the Trump administration proposes a $5.8 billion cut to the National Institutes of Health (NIH) and cuts to the Health and Human Services (HHS) emergency preparedness programs.
03/09/2017

IDSA Statement on the Repeal of the Prevention and Public Health Fund

The Infectious Diseases Society of America (IDSA) is deeply concerned that the proposed American Health Care Act under consideration in Congress would repeal the Prevention and Public Health Fund.
02/27/2017

IDSA Statement on WHO Priority AR Pathogen List

The Infectious Diseases Society of America welcomes today’s announcement from the World Health Organization of its “priority pathogens” list to guide and promote antibiotic research and development. We call upon United States policy makers and international leaders to commit the resources necessary to realize the goals of this list.
02/16/2017

Complex Neurological Infections Require Team Care

A team approach is vital to the successful diagnosis and treatment of complex neurological infections related to placement of devices in the brain, or as a result of neurosurgery or head trauma. This is among the recommendations in the first comprehensive guidelines on healthcare-associated ventriculitis and meningitis, which are being released by the Infectious Diseases Society of America (IDSA) and published in the journal Clinical Infectious Diseases.
02/10/2017

IDSA Statement on the Confirmation of Tom Price as Secretary of Health and Human Services

The Infectious Diseases Society of America is committed to working with Secretary Price, confirmed today by the U.S. Senate as the new Secretary of the Department of Health and Human Services.
02/02/2017

IDSA Statement on Exec. Order on Travel to U.S.

Infectious diseases do not respect national borders, and success in fighting them requires a global response. Broad international collaboration is critical to our ability to identify, track and respond to emerging infectious diseases. 
01/11/2017

IDSA Statement on Vaccines

The Infectious Diseases Society of America (IDSA) stands behind the overwhelming scientific evidence that has repeatedly demonstrated the overall safety and benefit of routine childhood vaccinations. Children are far more likely to be harmed by vaccine preventable illness, such as measles, than by the vaccines that prevent such infections.
//

High-Dose Flu Vaccine Better Preventing Deaths in Seniors
//

A JID studysuggests the high-dose flu vaccine was more effective at preventing deaths among seniors than the standard-dose vaccine during a more severe flu season.
//

High-Dose Flu Vaccine Better at Preventing Deaths in Seniors
//

//

The Infectious Diseases Society of America (IDSA) is deeply concerned that the proposed American Health Care Act under consideration in Congress would repeal the Prevention and Public Health Fund.
//

//

The Infectious Diseases Society of America (IDSA) is deeply troubled that the budget blueprint released today by the Trump administration proposes a $5.8 billion cut to the National Institutes of Health (NIH) and cuts to the Health and Human Services (HHS) emergency preparedness programs.
//

//

//

The Infectious Diseases Society of America and HIV Medicine Association have also launched a broader campaign to call upon Congress to protect all NIH infectious diseases research funding.
//

| HIVMA | Contact Us

© Copyright IDSA 2017 Infectious Diseases Society of America

Full Site Mobile Site